Vanda Pharmaceuticals announces the publication of an article titled “Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S”
Press Releases
February 24, 2025

Vanda Pharmaceuticals announces the publication of an article titled “Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S”

WASHINGTON, Feb. 24, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article entitled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S" in

bradford

The Bradford Era

Local & Social